Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-004931
Filing Date
2025-01-13
Accepted
2025-01-13 17:35:48
Documents
1
Period of Report
2025-01-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2956
  Complete submission text file 0000950170-25-004931.txt   4361
Mailing Address C/O MIRNA THERAPEUTICS, INC. 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
DeYoung Casi (Reporting) CIK: 0001652066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39593 | Film No.: 25527202

Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Issuer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)